Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biochemical Changes and Molecular Mechanisms Mediated by Sulfur Dioxide in Healthy Skin and Dermatological Disorders.

Biomolecules·2026
Same author

Novel Respiratory Breath Hold Index: A Predictor for Successful Extubation in Mechanically Ventilated Patients, a Prospective Cohort Study.

Life (Basel, Switzerland)·2025
Same author

[NAEGLERIA FOWLERI AMOEBA MENINGITIS - REVIEW AND UPDATE].

Harefuah·2025
Same author

From Fat to Muscle.

The Israel Medical Association journal : IMAJ·2025
Same author

Development and Validation of a Clinical Protocol in COVID-19 Patients to Assess Disease Severity and Outcomes.

The Israel Medical Association journal : IMAJ·2025
Same author

Proprotein Convertase Subtilisin Kexin 9 Inhibitor in Severe Sepsis and Septic Shock Patients in a Phase II Prospective Cohort Study-Preliminary Results.

Infectious disease reports·2024

Related Experiment Video

Updated: Dec 5, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.3K

Histiocytic Sarcoma

Milena Tocut1,2, Hanan Vaknine3,2, Paulina Potachenko4

  • 1Department of Internal Medicine C, Wolfson Medical Center, Holon, Israel.

The Israel Medical Association Journal : IMAJ
|October 18, 2020
PubMed
Summary
This summary is machine-generated.

Histiocytic sarcoma (HS) is a rare cancer from bone marrow cells. This aggressive malignancy often affects multiple organs and has a poor prognosis, with most patients succumbing within a year.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.3K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.9K

Related Experiment Videos

Last Updated: Dec 5, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.3K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.3K
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.9K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Histiocytic sarcoma (HS) is a rare hematopoietic malignancy.
  • It originates from the monocyte/macrophage bone marrow lineage.
  • HS can be associated with other hematological neoplasms like non-Hodgkin lymphoma (NHL).

Purpose of the Study:

  • To describe the origin and clinical presentation of histiocytic sarcoma.
  • To highlight the aggressive nature and poor prognosis of HS.
  • To provide an overview of HS affecting various organs.

Main Methods:

  • Literature review of histiocytic sarcoma cases.
  • Analysis of clinical data and pathological findings.
  • Review of associated hematological neoplasms.

Main Results:

  • Histiocytic sarcoma arises from monocytes/macrophages.
  • It can affect lymph nodes, GI tract, skin, bone marrow, spleen, and CNS.
  • The disease follows an aggressive course with a high mortality rate.

Conclusions:

  • Histiocytic sarcoma is a rare but aggressive hematologic malignancy.
  • Early diagnosis and understanding of its clinical behavior are crucial.
  • Further research is needed to improve treatment outcomes for HS patients.